FDA Clears New Device for Transseptal Heart Access
The system is designed to improve workflow efficiency and safety during minimally invasive left-heart procedures.
The system is designed to improve workflow efficiency and safety during minimally invasive left-heart procedures.
Boston Scientific will acquire Bolt Medical, developer of an intravascular lithotripsy (IVL) platform for artery disease.
Inspira Technologies has received FDA 510(k) class II clearance for its Inspira Art100 cardiopulmonary bypass system, which elevates patient oxygen levels quickly and may reduce the need for mechanical ventilation.
The system is designed to improve workflow efficiency and safety during minimally invasive left-heart procedures.
Getinge recalled the Cardiosave Hybrid and Rescue IABPs because they may shut down unexpectedly due to electrical failure.
Read MoreAcorai, a startup medical device manufacturer, announced that the FDA has granted Breakthrough Device Designation for Acorai’s Heart Monitor.
Read MoreGenesis MedTech announced that its J-Valve Transfemoral (TF) System has been granted Breakthrough Device designation by the FDA.
Read MoreMagAssist introduced its ECMO system BreathMo, which uses maglev technology to reduce the risk of blood damage.
Read MoreCardiawave SA, a deeptech medical device manufacturer that developed Valvosoft, a non-invasive medical device to treat aortic stenosis, announced the issuance of three new patents in the United States.
Read MoreThe U.S. FDA has approved BioVentrix’s application for an Expanded Access Program for the Revivent TC System to treat ischemic heart failure.
Read More
Getinge is recalling IABP devices due to a compromised intra-aortic balloon causing blood to enter the IABP during therapy.